TKL is awarded Bill and Melinda Gates Foundation Grand Challenges funding.

Written By Mireille Kamariza

TKL will collaborate with the Myhrvold Lab (Princeton University) to develop CRISPR-based assays to rapidly detect multiple drug resistance mutations in Plasmodium falciparum and Mycobacterium tuberculosis for malaria and tuberculosis (TB) surveillance, respectively.

Mireille Kamariza
Previous

TKL members attend the 2023 Annual Biomedical Research Conference for Minority Scientists (ABRCMS).
Next

Zahra Azhar joins TKL for a fall rotation